TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2142486
Drug: Teicoplanin therapy
Normalized name: teicoplanin
DrugBank: Teicoplanin (DB06149)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Teicoplanin therapy
Study: 12105117
Drug: Repeated administration
Normalized name: eicosyl povidone (2 eicosyl branches-repeat)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Repeated administration of MDMA (3,4-methylenedioxymethamphetamine)
Study: 6689038
Drug: Calcitriol administration
Normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Calcitriol administration (0.75 micrograms every 6 hr)
Study: 6689038
Drug: Calcitriol administration
Normalized name: Calcitriol
DrugBank: Calcitriol (DB00136)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Calcitriol administration
Study: 15480130
Drug: Combination Therapy
Normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination Therapy (CT)
Study: 15480130
Drug: Interferential Therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Interferential Therapy (IFT)
Study: 25893426
Drug: oral fat
Normalized name: Hard fat
DrugBank: Hard fat (DB11578)
Approvals — FDA: no, EMA: no, PMDA: no
Description: oral fat
Study: 23192700
Drug: Radiotherapy concurrently
Normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Radiotherapy concurrently with weekly cisplatin
Study: 30202030
Drug: Celecoxib with
Normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Celecoxib with TB drugs
Study: 28596511
Drug: Alprazolam 0.5
Normalized name: alprazolam 0.5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Alprazolam 0.5 mg orally one hour before the operation (G1, G3)
Study: 16677640
Drug: Clomiphene citrate
Normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Clomiphene citrate 100 mg/day
Study: 9308928
Drug: Etanidazole combined
Normalized name: Tinidazole
DrugBank: Tinidazole (DB00911)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Etanidazole combined with radiotherapy (2 g/m2, three times weekly for 17 doses)
Study: 24988909
Drug: Flurbiprofen 8.75
Normalized name: flurbiprofen 8.75 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Flurbiprofen 8.75 mg lozenges (n=101)
Study: 9721958
Drug: Azithromycin 500
Normalized name: azithromycin 500 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Azithromycin 500 mg once daily for 3 days
Study: 28271623
Drug: Probiotic capsule
Normalized name: GNP Probiotic Capsule
DrugBank: Bifidobacterium longum (DB19248)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Probiotic capsule (BIO-25)
Study: 8353575
Drug: Heparinized flush
Normalized name: T8 Keto Flush
Approvals — FDA: no, EMA: no, PMDA: no
Description: Heparinized flush solutions
Study: 2962603
Drug: Metrizoate 350
Normalized name: Metrifonate
DrugBank: Metrifonate (DB11473)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Metrizoate 350 mg I/ml
Study: 8427753
Drug: Iohexol 350
Normalized name: iohexol 350 mg/mL injectable solution
Approvals — FDA: no, EMA: no, PMDA: no
Description: Iohexol 350 mg I/ml
Study: 28893244
Drug: Omarigliptin 25
Normalized name: Omarigliptin
DrugBank: Omarigliptin (DB11992)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Omarigliptin 25 mg once weekly (q.w.)
Study: 26802156
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of cediranib 30 mg once daily and saracatinib 175 mg once daily (CS)
Study: 2936564
Drug: Nafarelin acetate
Normalized name: Nafarelin Acetate
DrugBank: Nafarelin (DB00666)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nafarelin acetate 250 micrograms daily
Study: 10947304
Drug: Misoprostol plus
Normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Misoprostol plus any NSAID therapy
Study: 23126367
Drug: Grapefruit juice
Normalized name: grapefruit juice
Approvals — FDA: no, EMA: no, PMDA: no
Description: Grapefruit juice (200 ml thrice daily for 4 days)
Study: 8590144
Drug: Combination therapy
Normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination therapy of 3 x 600 mg bismuth subsalicylate and 2 x 1000 mg amoxycillin
Study: 21075163
Drug: Test vaccine
Normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Test vaccine recipients
Study: 29027598
Drug: Paclitaxel 80
Normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Paclitaxel 80 mg/m2 plus pelareorep 3 × 10^10 TCID50
Study: 20150283
Drug: Intensive therapy
Normalized name: Cortaid Intensive Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intensive therapy (INT)
Study: 1790313
Drug: Freeze-dried sodium
Normalized name: BLACKBERRY MESOCARP FREEZE DRIED
Approvals — FDA: no, EMA: no, PMDA: no
Description: Freeze-dried sodium phenytoin-milk formulation
Study: 16096179
Drug: Pimecrolimus cream
Normalized name: Pimecrolimus
DrugBank: Pimecrolimus (DB00337)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Pimecrolimus cream 1% applied four times daily (QID)
Study: 11792138
Drug: Early conservative
Normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Early conservative therapy
Study: 22805468
Drug: Fish oil
Normalized name: Fish oil
DrugBank: Fish oil (DB13961)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Fish oil supplementation (280 mg DHA and 110 mg EPA daily)
Study: 11469844
Drug: Preoperative administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Preoperative administration of ampiroxicam
Study: 29606861
Drug: GFF MDI
Normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
Approvals — FDA: no, EMA: no, PMDA: no
Description: GFF MDI 14.4/10 μg
Study: 9056049
Drug: Activated charcoal
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Activated charcoal administered 2 hours after amlodipine
Study: 11869770
Drug: Divalproex sodium
Normalized name: Divalproex Sodium
DrugBank: Valproic acid (DB00313)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Divalproex sodium (DVPX) monotherapy, mean dose 882 mg qhs, mean level 80.7 mug/ml
Study: 23176547
Drug: 30-week oral
Normalized name: lacosamide
DrugBank: Lacosamide (DB06218)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: 30-week oral language intervention
Study: 16338507
Drug: Albuterol nebulized
Normalized name: Albuterol
DrugBank: Albuterol (DB01001)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Albuterol nebulized in heliox
Study: 24914630
Drug: 12 mL
Normalized name: syringe, disposable, 12 mL
Approvals — FDA: no, EMA: no, PMDA: no
Description: 12 mL mepivacaine 2% (group concentration I)
Study: 9163263
Drug: Prilocaine 650
Normalized name: Prilocaine
DrugBank: Prilocaine (DB00750)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Prilocaine 650 mg
Study: 1607520
Drug: Accelerated 90-min
Normalized name: Serum prothrombin conversion accelerator
DrugBank: Coagulation factor VII human (DB13150)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Accelerated 90-min regimen of rt-PA (100 mg total)
Study: 18555937
Drug: G-ER QD
Normalized name: quinidine gluconate Extended Release Oral Tablet [Quin-G]
Approvals — FDA: no, EMA: no, PMDA: no
Description: G-ER QD (1800 mg at 8 pm)
Study: 16776753
Drug: Moxonidine 0.2
Normalized name: moxonidine 0.2 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Moxonidine 0.2 mg twice daily for 16 weeks
Study: 1433582
Drug: Medical treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Medical treatment (155 children)
Study: 24120032
Drug: Energy-restricted diet
Normalized name: Senergy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Energy-restricted diet enriched in n-3 PUFAs (20 kcal/kg/ideal body weight/day, average 2.6 g/d)
Study: 22613740
Drug: Diuretic treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Diuretic treatment (spironolactone, 100 mg day(-1) for 3 days)
Study: 11348716
Drug: Influenza vaccine
Normalized name: Influenza vaccine
Approvals — FDA: no, EMA: no, PMDA: no
Description: Influenza vaccine (administered to ambulatory clinic patients)
Study: 11317060
Drug: Herbal medicines
Normalized name: Percy Medicine
DrugBank: Bismuth subsalicylate (DB01294)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Herbal medicines
Study: 23136538
Drug: Single-dose parecoxib
Normalized name: parecoxib
DrugBank: Parecoxib (DB08439)
Approvals — FDA: no, EMA: yes, PMDA: no
Description: Single-dose parecoxib (40mg at 30min before the end of surgery)
Study: 16442481
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (not explicitly defined, but implied as standard morphine treatment without midazolam)
Study: 8269574
Drug: Fresh gas
Normalized name: Peroxi-Fresh
Approvals — FDA: no, EMA: no, PMDA: no
Description: Fresh gas flow rates of 10.4 L.min‐1
Study: 12670812
Drug: Intrathecal +
Normalized name: beractant
DrugBank: Beractant (DB06761)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intrathecal + PCA morphine (IT+PCA)
Study: 30376884
Drug: Eplerenone 25
Normalized name: eplerenone 25 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Eplerenone 25 mg every 12 hours for 4 days (first dose prior to kidney transplantation)
Study: 9104903
Drug: Aspirin 200
Normalized name: aspirin 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Aspirin 200 mg/day, ticlopidine 500 mg/day, and warfarin for 1 month (group 1)
Study: 19770473
Drug: Telcagepant 300
Normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Telcagepant 300 mg
Study: 19770473
Drug: Telcagepant 150
Normalized name: Telcagepant
DrugBank: Telcagepant (DB12228)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Telcagepant 150 mg
Study: 21813569
Drug: Transfer into
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Transfer into an open cot at 1800 g
Study: 16766975
Drug: Negative pressure
Normalized name: DRESSING,NEGATIVE PRESSURE WOUND
Approvals — FDA: no, EMA: no, PMDA: no
Description: Negative pressure wound therapy (VAC) for fractures
Study: 18094221
Drug: 600 mg
Normalized name: mesna 600 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 600 mg rifampin
Study: 23904465
Drug: BPA exposure
Normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
Approvals — FDA: no, EMA: no, PMDA: no
Description: BPA exposure (20, 200 ng/ml or 20 µg/ml)
Study: 22278344
Drug: 126 mg
Normalized name: glycerin 126 MG/ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: 126 mg soy germ isoflavones
Study: 8316616
Drug: Triphasic oral
Normalized name: CeeNU, triphasic oral capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Triphasic oral contraceptive (OC)
Study: 3378514
Drug: Atenolol 50mg
Normalized name: ATENOLOL 50MG TAB
DrugBank: Atenolol (DB00335)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Atenolol 50mg twice daily with sustained release nifedipine 40mg twice daily
Study: 27628038
Drug: Qing-Xin-Jie-Yu Granules
Normalized name: Bai jie seed
DrugBank: White mustard seed (DB15606)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Qing-Xin-Jie-Yu Granules (QXJYG), twice daily for 6 months
Study: 19043609
Drug: Combined therapy
Normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combined therapy (inhalation and intravenous antibiotics)
Study: 9272406
Drug: Combined treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combined treatment (Valsartan + Furosemide)
Study: 29443538
Drug: Physical therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Physical therapy (12-session supervised clinic program)
Study: 7514046
Drug: Erythropoietin (Epo)
Normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Erythropoietin (Epo) and G-CSF
Study: 26920590
Drug: Drug-eluting stents
Normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Drug-eluting stents (DES) - sirolimus-eluting stents (SES) and everolimus-eluting stents (EES)
Study: 28095573
Drug: Vehicle twice
Normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vehicle twice daily
Study: 25240075
Drug: Total parenteral
Normalized name: TPN - total parenteral nutrition
Approvals — FDA: no, EMA: no, PMDA: no
Description: Total parenteral nutrition (TPN)
Study: 22517217
Drug: Amlodipine (AM)
DrugBank: Amlodipine (DB00381)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amlodipine (AM) 5 mg
Study: 12151999
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg efavirenz
Study: 7740377
Drug: 4-drug regimen
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: 4-drug regimen (isoniazid, rifampicin, pyrazinamide, ethambutol)
Study: 14504812
Drug: Itraconazole solution
Normalized name: Itraconazole
DrugBank: Itraconazole (DB01167)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Itraconazole solution
Study: 14504812
Drug: Amphotericin B
Normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amphotericin B solution
Study: 24603562
Drug: Early supplementing
Normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Early supplementing enteral Microlipid (ML) and fish oil (FO)
Study: 3291901
Drug: Split-course treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Split-course treatment (227 patients)
Study: 28129746
Drug: Graded Exercise
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Graded Exercise Therapy (GET)
Study: 18414712
Drug: Oral cannabinoid-containing
Normalized name: Cannabinol
DrugBank: Cannabinol (DB14737)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral cannabinoid-containing medications (OCs)
Study: 22266603
Drug: 48-week pegylated
Normalized name: Pegylated rfviii
DrugBank: PEGylated Recombinant Factor VIII (DB16093)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 48-week pegylated interferon (PEG-IFN) alfa-2a 180 mcg/week and ribavirin (RBV) 15mg/kg/day
Study: 7956700
Drug: Tumor infiltrating
Normalized name: Autologous tumor infiltrating lymphocytes
DrugBank: Lifileucel (DB17107)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tumor infiltrating lymphocytes (TILs) immunotherapy
Study: 17540797
Drug: Quick Start
Normalized name: Cal-Quick
Approvals — FDA: no, EMA: no, PMDA: no
Description: Quick Start (immediate, directly observed ingestion of the first pill during the clinic visit)
Study: 15467969
Drug: Antidepressive treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Antidepressive treatment for 35 days
Study: 31053896
Drug: N2O inhalation
Normalized name: N2O
DrugBank: Nitrous oxide (DB06690)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: N2O inhalation sedation or general anesthesia
Study: 14623834
Drug: 50 mg
Normalized name: talc 50 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 50 mg sodium diclofenac
Study: 29582237
Drug: Dabigatran 110
Normalized name: dabigatran 110 mg oral capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dabigatran 110 mg BID (D110)
Study: 29582237
Drug: Dabigatran 150
Normalized name: dabigatran 150 mg oral capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dabigatran 150 mg BID (D150)
Study: 28484877
Drug: Celecoxib with
Normalized name: Celecoxib
DrugBank: Celecoxib (DB00482)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Celecoxib with morphine sulfate 10 mg/12 h
Study: 15011890
Drug: Eradication therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Eradication therapy (omeprazole, amoxicillin, and clarithromycin)
Study: 2223363
Drug: Propofol infusion
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Propofol infusion at 300 ml h‐1
Study: 2223363
Drug: Propofol infusion
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Propofol infusion at 1200 ml h‐1
Study: 23895801
Drug: Low-dose methotrexate
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose methotrexate (target dose 15-20 mg/wk)
Study: 7611158
Drug: Nicotinic acid
Normalized name: Nicotinic acid
DrugBank: Niacin (DB00627)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nicotinic acid and lovastatin combination
Study: 2775618
Drug: Aminoglycoside dosage
Normalized name: osage orange pollen extract
DrugBank: Maclura pomifera pollen (DB10988)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Aminoglycoside dosage based on pharmacokinetic analysis
Study: 9010943
Drug: Transdermal fentanyl
Normalized name: fentanyl Transdermal System
DrugBank: Fentanyl (DB00813)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Transdermal fentanyl patch (0.16 mg/cm2) applied 60 minutes before anesthesia induction.
Study: 3549804
Drug: 2% minoxidil
Normalized name: MINOXIDIL 2 g in 100 mL TOPICAL LIQUID [2% Minoxidil hair growth serum]
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2% minoxidil solution
Study: 23792179
Drug: Antidepressant Medication
Normalized name: ANTIDEPRESSANTS
Approvals — FDA: no, EMA: no, PMDA: no
Description: Antidepressant Medication (ADM) - unspecified dosage and duration
Study: 11361050
Drug: Hydrocortisone acetate
Normalized name: Hydrocortisone Acetate
DrugBank: Hydrocortisone succinate (DB14545)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Hydrocortisone acetate foam (100 mg)
Study: 22776014
Drug: Teneligliptin 10
Normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Teneligliptin 10 mg
Study: 30362280
Drug: Teneligliptin 20
Normalized name: teneligliptin
DrugBank: Teneligliptin (DB11950)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Teneligliptin 20 mg
Study: 12854936
Drug: Writing therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Writing therapy intervention
Study: 14764783
Drug: Low-dose recombinant
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose recombinant human growth hormone (rhGH)
Study: 19138370
Drug: Topical alprostadil
Normalized name: Alprostadil
DrugBank: Alprostadil (DB00770)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Topical alprostadil cream (200 mcg initially, then adjusted)
Study: 24429155
Drug: Nebulised magnesium
Normalized name: Magnesium
DrugBank: Magnesium (DB14513)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Nebulised magnesium sulphate (MgSO4) 2.5 mL (250 mmol/L; 151 mg per dose)
Study: 31288822
Drug: Propofol with
Normalized name: propofol with medium chain triglycerides 10 mg/mL intravenous emulsion
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propofol with placebo (0.9% sodium chloride solution)
Study: 12789991
Drug: Colgate Simply
Normalized name: Colgate
DrugBank: Sodium fluoride (DB09325)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Colgate Simply White Clear Whitening Gel (18% carbamide peroxide)
Study: 12445410
Drug: Naltrexone 50
Normalized name: naltrexone 50 mg oral tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Naltrexone 50 mg/day
Study: 22301107
Drug: Drug-releasing implants
Normalized name: Drug Implant
Approvals — FDA: no, EMA: no, PMDA: no
Description: Drug-releasing implants
Study: 6768078
Drug: Heroin self-administration
Normalized name: heroin
DrugBank: Diamorphine (DB01452)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Heroin self-administration with buprenorphine placebo
Study: 7452507
Drug: Heroin self-administration
Normalized name: heroin
DrugBank: Diamorphine (DB01452)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Heroin self-administration
Study: 17452486
Drug: Higher dose
Normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Higher dose of rifampin (600 mg)
Study: 19667111
Drug: Adiponectin neutralizing
Normalized name: DentiCare Neutral
Approvals — FDA: no, EMA: no, PMDA: no
Description: Adiponectin neutralizing antibody
Study: 17454036
Drug: Controlled release
Normalized name: EpiCeram Controlled Release Skin Barrier Emulsion
Approvals — FDA: no, EMA: no, PMDA: no
Description: Controlled release (CR) tablets of naproxen sodium
Study: 17454036
Drug: Marketed immediate
Normalized name: acetaminophen
DrugBank: Acetaminophen (DB00316)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Marketed immediate release tablets of naproxen sodium
Study: 31896686
Drug: Systemic treatment
Normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Systemic treatment (validation set)
Study: 26994634
Drug: Opioid pain
Normalized name: Dermoplast Pain
Approvals — FDA: no, EMA: no, PMDA: no
Description: Opioid pain medications
Study: 17209507
Drug: Ramipril 15
Normalized name: Ramipril
DrugBank: Ramipril (DB00178)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Ramipril 15 mg/day
Study: 25914349
Drug: All groups
Normalized name: All Clear
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: All groups (10, 20, 40 injections)
Study: 1928881
Drug: Codeine/acetaminophen
Normalized name: PE/codeine/acetaminophen/cpm ORAL ELIXIR
Approvals — FDA: no, EMA: no, PMDA: no
Description: Codeine/acetaminophen
Study: 3141537
Drug: N-hydroxy-arachidonamide (AH)
Normalized name: N-ethyl-3-hydroxy-N,N-dimethylanilinium
DrugBank: Edrophonium (DB01010)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: N-hydroxy-arachidonamide (AH) (topical)
Study: 3141537
Drug: Phenidone (topical)
Normalized name: phenindione
DrugBank: Phenindione (DB00498)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Phenidone (topical)
Study: 9773735
Drug: Premeal human
Normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Premeal human regular insulin before lunch and supper at unchanged dose
Study: 9773735
Drug: Premeal lispro
Normalized name: Insulin Lispro
DrugBank: Insulin lispro (DB00046)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Premeal lispro (unchanged dose) at lunchtime and dinner
Study: 7027714
Drug: Iv glipizide
Normalized name: Glipizide
DrugBank: Glipizide (DB01067)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Iv glipizide followed 60 min later by oral glucose
Study: 2322970
Drug: 3 ml
Normalized name: WATER,INHL 3 ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: 3 ml saline injected prior to catheter insertion
Study: 19797937
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg controlled-release tramadol